Form 4: RxSight Executive Ilya Goldshleger Exercises Options and Sells Shares Under 10b5-1 Plan

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 22, 2024, Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options to acquire 3,100 shares of common stock at a price of $15.08 per share.
• Simultaneously, Goldshleger sold 3,100 shares of common stock at a weighted average price of $49.6778, within a price range of $49.50 to $50.105.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on June 3, 2024.
• Following these transactions, Goldshleger directly owns 42,246 shares of RxSight common stock and indirectly owns 1,372 shares through a spouse.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, as it simply reports facts.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares, especially under pre-arranged trading plans like Rule 10b5-1, which allows insiders to trade without being accused of acting on non-public information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-arranged nature of the trades mitigates concerns about insider information.

Key Dates